Calls
1
u/TraditionPrimary6781
Reddit r/pennystocks
Win Rate
100.0%
return
+43.7%
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Jan 20
$5.90
+43.7%
The author argues ImmunityBio's Anktiva, a superagonist fusion complex that activates NK and memory T cells, has shown long-term success with extensive data but has not been reviewed by the FDA. Saudi Arabia has approved Anktiva for use, and the author suggests this foreign success could pressure the FDA to approve it in the US, or force Americans into medical tourism. The implied catalyst is FDA review/approval of Anktiva.
Pharma & Biotech
Showing 1 of 1 calls · sorted by mentions
Choose a mentions count to open ticker posts.
u/TraditionPrimary6781 has 1 trade ideas tracked on Buzzberg across 1 tickers since January 2026. Most covered: IBRX.
Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology
